Skip to content

Depression: all studies

Page 421 of 1,034: studies 4,201 to 4,210 of 10,336, newest first. Back to the depression overview

Research

Glutamatergic Modulators: The Future of Treating Mood Disorders?

Harvard Review of Psychiatry August 1, 2010 Carlos A. Zarate, Rodrigo Machado‐Vieira, Ioline D. Henter et al. 226 citations

Mood disorders such as bipolar disorder and major depressive disorder are common, chronic, and recurrent conditions affecting millions of individuals worldwide. Existing antidepressants and mood stabilizers used to treat these disorders are insufficient for many. Patients continue to have low remission rates, delayed onset of action, residual subsyndromal symptoms, and relapses. New therapeutic...

The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments.

Pharmaceuticals January 6, 2010 Rodrigo Machado‐Vieira, Jacqueline Baumann, Cristina Wheeler-Castillo et al.

Currently available antidepressants used to treat major depressive disorder (MDD) unfortunately often take weeks to months to achieve their full effects, commonly resulting in considerable morbidity and increased risk for suicidal behavior. Our lack of understanding of the precise cellular underpinnings of this illness and of the mechanism of action of existing effective pharmacological...

Feasibility and effectiveness of a brief meditation-based stress management intervention for patients diagnosed with or at risk for coronary heart disease: a pilot study.

Psychology, Health & Medicine October 1, 2009 Erin L Olivo, Brooke Dodson-Lavelle, Anava A Wren et al.

Feasibility and effectiveness of a brief meditation-based stress management intervention for patients diagnosed with or at risk for coronary heart disease: a pilot study.

Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to anN-Methyl-D-Aspartate Antagonist

The Journal of Clinical Psychiatry September 8, 2009 Rodrigo Machado‐Vieira, Peixiong Yuan, Nancy E. Brutsché et al. 154 citations

OBJECTIVE: A model has been proposed to explain the pathophysiology of mood disorders based on decreased neurotrophin levels during mood episodes; treatment with antidepressants and mood stabilizers is associated with clinical improvement. This study investigated whether changes in brain-derived neurotrophic factor (BDNF) levels are associated with the initial antidepressant effects of...

Yoga ameliorates performance anxiety and mood disturbance in young professional musicians.

Applied Psychophysiology and Biofeedback August 6, 2009 Sat Bir S Khalsa, Stephanie M Shorter, Stephen Cope et al.

Yoga and meditation can alleviate stress, anxiety, mood disturbance, and musculoskeletal problems, and can enhance cognitive and physical performance. Professional musicians experience high levels of stress, performance anxiety, and debilitating performance-related musculoskeletal disorders (PRMDs). The goal of this controlled study was to evaluate the benefits of yoga and meditation for...

Impact of REM sleep on distortions of self-concept, mood and memory in depressed/anxious participants.

Journal of Affective Disorders July 24, 2009 Patrick Mcnamara, Sanford Auerbach, Patricia Johnson et al.

Introduction: We tested the hypothesis that REM sleep contributes to core features of cognitive dysfunction of anxious depression including negative self-appraisals, biased memory processing and unpleasant dream content. Methods: After a habituation night in a sleep lab, a convenience sample of 35 healthy college students and 20 depressed/anxious students were awakened 10 min into a REM sleep...

Anomalous subjective experience and psychosis risk in young depressed patients.

Psychopathology May 16, 2009 Erika Szily, Szabolcs Kéri

Background: Help-seeking young people often display depressive symptoms. In some patients, these symptoms may co-exist with clinically high-risk mental states for psychosis. The aim of this study was to determine differences in subjective experience and social perception in young depressed patients with and without psychosis risk. Methods: Participants were 68 young persons with major...

A defined network of fast-spiking interneurons in orbitofrontal cortex: responses to behavioral contingencies and ketamine administration.

Frontiers in Systems Neuroscience 2009 Michael C. Quirk, Dara L Sosulski, Claudia E Feierstein et al.

Orbitofrontal cortex (OFC) is a region of prefrontal cortex implicated in the motivational control of behavior and in related abnormalities seen in psychosis and depression. It has been hypothesized that a critical mechanism in these disorders is the dysfunction of GABAergic interneurons that normally regulate prefrontal information processing. Here, we studied a subclass of interneurons...

Dreams by persons with mood disorders.

Psychological Reports October 1, 2008 Marco Zanasi, Martina Pecorella, Carlo Chiaramonte et al.

This work evaluated the structure of dreams in depressed patients. The verbal reports of dreams of 100 depressed patients were compared with 251 dreams of a control group. In accordance with the Jungian thought, which views dreams as texts, dream reports were assessed using textual analysis processing techniques. Significant differences were found in parameter values, as well as in the role of...

Diagnosis and distress in Navajo healing.

The Journal of Nervous and Mental Disease August 1, 2008 Thomas J Csordas, Michael J Storck, Milton Strauss

In contemporary Navajo society, traditional Navajo ceremonies, Native American Church prayer meetings, and Navajo Christian faith healing are all highly sought-after resources in the everyday pursuit of health and well-being. What is the nature of affliction among patients who turn to such forms of religious healing? Are these patients typically afflicted with psychiatric disorder? In this...